We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Bayer Acquires Imaging AI Platform Provider in the UK

By MedImaging International staff writers
Posted on 20 Jan 2023
Print article
Blackford has the widest available portfolio of imaging AI solutions (Photo courtesy of Blackford Analysis)
Blackford has the widest available portfolio of imaging AI solutions (Photo courtesy of Blackford Analysis)

The global medical imaging AI market recorded sales in excess of USD 400 mn in 2021 and is expected to continue growing dynamically, with an estimated CAGR of more than 26% (2020 to 2026) to reach USD 1.36 billion by 2026. There is a huge need for innovation powered by AI as aging populations and changing lifestyles are driving an increase in chronic conditions, such as cardiovascular disease and cancer. As a result, the demand for medical imaging for detecting diseases, guiding treatment decisions and supporting therapy planning continues to grow. AI offers a value proposition of aiding diagnosis and increasing the throughput of radiological examinations. Now, a new acquisition aims to drive innovation in radiology, including the development and adoption of AI within the clinical workflow, with the goal to ultimately improve patient care.

Bayer (Leverkusen, Germany) has acquired Blackford Analysis Ltd. (Edinburgh, UK), a global strategic imaging AI platform and solutions provider. The acquisition is part of Bayer's strategy to drive innovation in radiology, including the development and adoption of AI within the clinical workflow, with the goal to ultimately improve patient care and advance the company’s position in digital medical imaging. Blackford provides infrastructure and access to a rich clinical application (ClinApp) ecosystem focused on imaging and analytics. The acquisition follows a development and license agreement between both companies in 2020 that laid the foundation for Bayer’s recently launched medical imaging platform, Calantic Digital Solutions. Building on technology from Blackford and adding additional workflow and analytics components, Calantic Digital Solutions delivers access to applications, including those enabled by AI, for medical imaging.

Blackford will continue to operate as an independent organization on an arm’s length basis to preserve its entrepreneurial culture as an essential pillar for nurturing successful innovation. The company will remain accountable to advance its technology, channel partnerships and ClinApp portfolio while benefiting from the experience, infrastructure and reach of Bayer as a global pharmaceutical company. The acquisition is expected to close later this year, pending the satisfaction of customary closing conditions.

“Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceutical Division. “This acquisition complements our comprehensive radiology portfolio and nourishes our engagement to drive innovation in digital health. We are pleased to join forces with Blackford and their exceptional team to optimally utilize our combined expertise in healthcare technology with the aim to deliver true value to radiologists and their teams for the benefit of their patients.”

“Blackford exists to improve the lives of patients and populations by unlocking the adoption and benefits of medical imaging AI. We investigated many routes to scale our business to deliver our mission and were delighted by Bayer’s invitation to deepen our partnership, whilst continuing to operate independently based on Bayer’s well-established arm’s length model,” said Ben Panter, Chief Executive Officer, Blackford Analysis. “Combining our knowledge and experience as one of the leading platform providers in the industry with Bayer’s advanced radiology portfolio will enable us to provide solutions to deliver ongoing clinical value to radiologists and their teams.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Brachytherapy Planning System
Oncentra Brachy
Gold Member
Radiation QA Tool
Accu-Gold 3

Print article
Radcal

Channels

Radiography

view channel
Image: The study supports annual screening beginning at age 40 as the best way to diagnose cancer early (Photo courtesy of 123RF)

Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%

Breast cancer remains a leading cause of cancer-related deaths among women in the United States. Although studies have shown that regular mammography screenings can cut breast cancer fatalities by 40%,... Read more

MRI

view channel
Image: Researchers have created a new MRI brain extraction tool for neonates (Photo courtesy of 123RF)

Deep Learning Algorithm Performs Automatic Segmentation of Neonatal Brains from MR Images

Magnetic Resonance Imaging (MRI) is a vital tool in medical diagnostics, particularly because of its high-resolution images and superior soft tissue contrast, which make it crucial for brain evaluations.... Read more

Ultrasound

view channel
Mindray`s comprehensive range of ultrasound machines include the Resona I9 (photo courtesy of Mindray)

Non-Invasive Ultrasound Technique Helps Identify Life-Changing Complications after Neck Surgery

Nasopharyngoscopy is an intrusive diagnostic medical procedure that involves the examination of the internal structures of the nose and throat (nasopharynx) using an endoscope inserted through the patient’s nose.... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: The new AI-enabled CT 5300 aims to bring confident diagnosis to more patients at low cost (Photo courtesy of Royal Philips)

AI-Enabled CT System Provides More Accurate and Reliable Imaging Results

Computed Tomography (CT) plays a critical role in diagnosing cardiac diseases. Recent research advocates a "CT first" approach for patients with chest pain and undiagnosed coronary artery disease, thus... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.